For Media: UK Press Releases
This page contains resources intended for journalists only. For media enquiries about our press releases please contact ukmediaenquiries@bayer.com
Mirena® (52mg levonorgestrel IUS) authorised in the UK for extended use up to eight years for contraception
Scottish Medicines Consortium (SMC) recommends two Bayer cancer treatments for use within NHSScotland
17 - 22of 22 News
17 - 22of 22 News